Ostby PL, Armer JM, Smith K, Stewart BR (2018) Patient perceptions of barriers to self-management of breast cancer-related lymphedema. West J Nurs Res 40:1800–1817. https://doi.org/10.1177/0193945917744351
Sun F, Hall A, Tighe MP, Brunelle CL, Sayegh HE, Gillespie TC, Daniell KM, Taghian AG (2018) Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema. Breast Cancer Res Treat 172:83–91. https://doi.org/10.1007/s10549-018-4902-z
Article PubMed PubMed Central Google Scholar
Ridner SH, Bonner CM, Deng J, Sinclair VG (2012) Voices from the shadows: living with lymphedema. Cancer Nurs 35:E18-26. https://doi.org/10.1097/NCC.0b013e31821404c0
Article PubMed PubMed Central Google Scholar
Fu MR, Axelrod D, Cleland CM, Qiu Z, Guth AA, Kleinman R, Scagliola J, Haber J (2015) Symptom report in detecting breast cancer-related lymphedema. Breast Cancer (Dove Med Press) 7:345–352. https://doi.org/10.2147/BCTT.S87854
Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR (2008) Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study. J Clin Oncol 26:5689–5696. https://doi.org/10.1200/JCO.2008.16.4731
Article PubMed PubMed Central Google Scholar
Fu MR, Kang Y (2013) Psychosocial impact of living with cancer-related lymphedema. Semin Oncol Nurs 29:50–60. https://doi.org/10.1016/j.soncn.2012.11.007
De Vrieze T, Nevelsteen I, Thomis S, De Groef A, Tjalma WAA, Gebruers N, Devoogdt N (2020) What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review. Support Care Cancer 28:439–449. https://doi.org/10.1007/s00520-019-05101-8
Ridner SH, Shah C, Boyages J, Koelmeyer L, Ajkay N, DeSnyder SM, McLaughlin SA, Dietrich MS (2020) L-Dex, arm volume, and symptom trajectories 24 months after breast cancer surgery. Cancer Med 9:5164–5173. https://doi.org/10.1002/cam4.3188
Article PubMed PubMed Central Google Scholar
American Cancer Society (2022) Key statistics for breast cancer. https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html. Accessed 16 Jan 2023
Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, Cormier JN (2015) Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin 65:55–81. https://doi.org/10.3322/caac.21253
DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500–515. https://doi.org/10.1016/S1470-2045(13)70076-7
Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Ung OA, Dylke ES, French JR, Yee J, Koelmeyer L, Gaitatzis K (2016) Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast 28:29–36. https://doi.org/10.1016/j.breast.2016.04.011
Article CAS PubMed Google Scholar
Penn IW, Chang YC, Chuang E, Chen CM, Chung CF, Kuo CY, Chuang TY (2019) Risk factors and prediction model for persistent breast-cancer-related lymphedema: a 5-year cohort study. Support Care Cancer 27:991–1000. https://doi.org/10.1007/s00520-018-4388-6
Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, Miller LT, Fox KR, DeMichele A, Solin LJ (2010) Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomark Prev 19:2734–2746. https://doi.org/10.1158/1055-9965.EPI-09-1245
Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C (2009) The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 16:1959–1972. https://doi.org/10.1245/s10434-009-0452-2
Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG (2018) Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg 7:379–403. https://doi.org/10.21037/gs.2017.11.04
Article PubMed PubMed Central Google Scholar
Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, Kushi LH (2010) Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg (Chicago, Ill.: 1950) 145:1055–1063. https://doi.org/10.1001/archsurg.2010.231
Armer JM, Hulett JM, Bernas M, Ostby P, Stewart BR, Cormier JN (2013) Best practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Cancer Rep 5:134–144. https://doi.org/10.1007/s12609-013-0105-0
Article PubMed PubMed Central Google Scholar
Kwan JYY, Famiyeh P, Su J, Xu W, Kwan BYM, Jones JM, Chang E, Yip KW, Liu FF (2020) Development and validation of a risk model for breast cancer-related lymphedema. JAMA Netw Open 3:e2024373. https://doi.org/10.1001/jamanetworkopen.2020.24373
Article PubMed PubMed Central Google Scholar
Koelmeyer LA, Gaitatzis K, Dietrich MS, Shah CS, Boyages J, McLaughlin SA, Taback B, Stolldorf DP, Elder E, Hughes TM, French JR, Ngui N, Hsu JM, Moore A, Ridner SH (2022) Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention. Cancer 128:3408–3415. https://doi.org/10.1002/cncr.34377
Article CAS PubMed Google Scholar
McLaughlin SA, Brunelle CL, Taghian A (2020) Breast cancer-related lymphedema: risk factors, ccreening, management, and the impact of locoregional treatment. J Clin Oncol 38:2341–2350. https://doi.org/10.1200/JCO.19.02896
Article PubMed PubMed Central Google Scholar
Naoum GE, Roberts S, Brunelle CL, Shui AM, Salama L, Daniell K, Gillespie T, Bucci L, Smith BL, Ho AY, Taghian AG (2020) Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. J Clin Oncol 38:3430–3438. https://doi.org/10.1200/JCO.20.00459
Article PubMed PubMed Central Google Scholar
Card A, Crosby MA, Liu J, Lindstrom WA, Lucci A, Chang DW (2012) Reduced incidence of breast cancer-related lymphedema following mastectomy and breast reconstruction versus mastectomy alone. Plast Reconstr Surg 130:1169–1178. https://doi.org/10.1097/PRS.0b013e31826d0faa
Article CAS PubMed Google Scholar
Miller CL, Colwell AS, Horick N, Skolny MN, Jammallo LS, O’Toole JA, Shenouda MN, Sadek BT, Swaroop MN, Ferguson CM, Smith BL, Specht MC, Taghian AG (2016) Immediate implant reconstruction is associated with a reduced risk of lymphedema compared to mastectomy alone: a prospective cohort study. Ann Surg 263:399–405. https://doi.org/10.1097/SLA.0000000000001128
Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 35:561–564. https://doi.org/10.1200/JCO.2016.71.0947
Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL (2001) Arm edema in breast cancer patients. J Natl Cancer Inst 93:96–111. https://doi.org/10.1093/jnci/93.2.96
Article CAS PubMed Google Scholar
Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Chafe S, Nolan MC, Craighead P, Bowen J, McCready DR, Pritchard KI, Gelmon K, Murray Y, Chapman JA, Chen BE, Levine MN, Investigators MAS (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373:307–316. https://doi.org/10.1056/NEJMoa1415340
Article CAS PubMed PubMed Central Google Scholar
Bevilacqua JL, Kattan MW, Changhong Y, Koifman S, Mattos IE, Koifman RJ, Bergmann A (2012) Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol 19:2580–2589. https://doi.org/10.1245/s10434-012-2290-x
McDuff SGR, Mina AI, Brunelle CL, Salama L, Warren LEG, Abouegylah M, Swaroop M, Skolny MN, Asdourian M, Gillespie T, Daniell K, Sayegh HE, Naoum GE, Zheng H, Taghian AG (2019) Timing of lymphedema after treatment for breast cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys 103:62–70. https://doi.org/10.1016/j.ijrobp.2018.08.036
Miaskowski C, Dodd M, Paul SM, West C, Hamolsky D, Abrams G, Cooper BA, Elboim C, Neuhaus J, Schmidt BL, Smoot B, Aouizerat BE (2013) Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS ONE 8:e60164. https://doi.org/10.1371/journal.pone.0060164
Article CAS PubMed PubMed Central Google Scholar
McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5213–5219. https://doi.org/10.1200/JCO.2008.16.3725
Article PubMed PubMed Central Google Scholar
Montagna G, Zhang J, Sevilimedu V, Charyn J, Abbate K, Gomez EA, Mehrara B, Morrow M, Barrio AV (2022) Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema. JAMA Oncol 8:1195–1200. https://doi.org/10.1001/jamaoncol.2022.1628
Bucci LK, Brunelle CL, Bernstein MC, Shui AM, Gillespie TC, Roberts SA, Naoum GE, Taghian AG (2021) Subclinical lymphedema after treatment for breast cancer: risk of progression and considerations for early intervention. Ann Surg Oncol 28:8624–8633. https://doi.org/10.1245/s10434-021-10173-0
Whitworth P, Vicini F, Valente SA, Brownson K, DuPree B, Kohli M, Lawson L, Shah C (2022) Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data. J Cancer Surviv. https://doi.org/10.1007/s11764-022-01242-8
Koelmeyer LA, Borotkanics RJ, Alcorso J, Prah P, Winch CJ, Nakhel K, Dean CM, Boyages J (2019) Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care. Cancer 125:854–862. https://doi.org/10.1002/cncr.31873
留言 (0)